|
DAAM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.76899639170847E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.43679956821074E-10 |
| Normal-vs-Stage2 |
9.07489972057363E-10 |
| Normal-vs-Stage3 |
9.54719636681034E-11 |
| Normal-vs-Stage4 |
3.84015041987595E-12 |
| Stage1-vs-Stage2 |
7.807000E-01 |
| Stage1-vs-Stage3 |
6.077200E-01 |
| Stage1-vs-Stage4 |
4.453500E-02 |
| Stage2-vs-Stage3 |
9.259000E-01 |
| Stage2-vs-Stage4 |
2.309000E-01 |
| Stage3-vs-Stage4 |
2.167400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.45979952757148E-11 |
| Normal-vs-AfricanAmerican |
1.35960000002822E-06 |
| Normal-vs-Asian |
9.62490087630385E-11 |
| Caucasian-vs-AfricanAmerican |
2.746000E-01 |
| Caucasian-vs-Asian |
4.530200E-01 |
| AfricanAmerican-vs-Asian |
1.366350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00740527031462E-11 |
| Normal-vs-Female |
1.43310030509269E-10 |
| Male-vs-Female |
1.121380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.93820001451684E-10 |
| Normal-vs-Age(41-60Yrs) |
2.82780465710175E-11 |
| Normal-vs-Age(61-80Yrs) |
4.79980499790145E-11 |
| Normal-vs-Age(81-100Yrs) |
2.375800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.245040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.964210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.475600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.685200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.739400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.676800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.879200E-01 |
| Classical-VS-Follicular |
1.187580E-01 |
| Classical-VS-Other |
1.512760E-01 |
| Classical-VS-Normal |
7.34269978153179E-10 |
| Tall-VS-Follicular |
5.874000E-01 |
| Tall-VS-Other |
2.283200E-01 |
| Tall-VS-Normal |
1.16049999610013E-08 |
| Follicular-VS-Other |
3.880600E-01 |
| Follicular-VS-Normal |
7.9043993572725E-11 |
| Other-VS-Normal |
5.94700000022819E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.13830073039867E-11 |
| Normal-vs-N1 |
4.53992399229719E-12 |
| N0-vs-N1 |
2.145200E-01 |
|
|
